182 related articles for article (PubMed ID: 3042912)
1. Pathogenetic studies of motor fluctuations in Parkinson's disease.
Chase TN; Mouradian MM; Fabbrini G; Juncos JL
J Neural Transm Suppl; 1988; 27():3-10. PubMed ID: 3042912
[TBL] [Abstract][Full Text] [Related]
2. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies.
Mouradian MM; Juncos JL; Fabbrini G; Chase TN
Ann Neurol; 1987 Oct; 22(4):475-9. PubMed ID: 3435068
[TBL] [Abstract][Full Text] [Related]
3. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease.
Fabbrini G; Juncos J; Mouradian MM; Serrati C; Chase TN
Ann Neurol; 1987 Apr; 21(4):370-6. PubMed ID: 3579222
[TBL] [Abstract][Full Text] [Related]
4. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I.
Fabbrini G; Mouradian MM; Juncos JL; Schlegel J; Mohr E; Chase TN
Ann Neurol; 1988 Sep; 24(3):366-71. PubMed ID: 3228270
[TBL] [Abstract][Full Text] [Related]
5. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.
Mouradian MM; Juncos JL; Fabbrini G; Schlegel J; Bartko JJ; Chase TN
Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271
[TBL] [Abstract][Full Text] [Related]
6. Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.
Bravi D; Mouradian MM; Roberts JW; Davis TL; Sohn YH; Chase TN
Ann Neurol; 1994 Jul; 36(1):27-31. PubMed ID: 8024257
[TBL] [Abstract][Full Text] [Related]
7. Rationale for continuous dopaminomimetic therapy of Parkinson's disease.
Chase TN; Baronti F; Fabbrini G; Heuser IJ; Juncos JL; Mouradian MM
Neurology; 1989 Nov; 39(11 Suppl 2):7-10; discussion 19. PubMed ID: 2685653
[TBL] [Abstract][Full Text] [Related]
8. Concentration-effect relationship of levodopa in patients with Parkinson's disease.
Harder S; Baas H; Rietbrock S
Clin Pharmacokinet; 1995 Oct; 29(4):243-56. PubMed ID: 8549026
[TBL] [Abstract][Full Text] [Related]
9. Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management.
van Laar T
CNS Drugs; 2003; 17(7):475-89. PubMed ID: 12751918
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
[TBL] [Abstract][Full Text] [Related]
11. 3-O-methyldopa and motor fluctuations in Parkinson's disease.
Fabbrini G; Juncos JL; Mouradian MM; Serrati C; Chase TN
Neurology; 1987 May; 37(5):856-9. PubMed ID: 3574690
[TBL] [Abstract][Full Text] [Related]
12. The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.
Chase TN
Drugs; 1998; 55 Suppl 1():1-9. PubMed ID: 9483164
[TBL] [Abstract][Full Text] [Related]
13. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
Colosimo C; Merello M; Hughes AJ; Sieradzan K; Lees AJ
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):634-7. PubMed ID: 8648329
[TBL] [Abstract][Full Text] [Related]
14. Interventions to achieve tonic exposure to levodopa: delaying or preventing the onset of motor complications.
Luer MS
Pharmacotherapy; 1999 Nov; 19(11 Pt 2):169S-79S. PubMed ID: 10555945
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
Fénelon G; Giménez-Roldán S; Montastruc JL; Bermejo F; Durif F; Bourdeix I; Péré JJ; Galiano L; Schadrack J
J Neural Transm (Vienna); 2003 Mar; 110(3):239-51. PubMed ID: 12658373
[TBL] [Abstract][Full Text] [Related]
16. When do levodopa motor fluctuations first appear in Parkinson's disease?
Stocchi F; Jenner P; Obeso JA
Eur Neurol; 2010; 63(5):257-66. PubMed ID: 20332641
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic considerations in management of motor response fluctuations in Parkinson's disease.
Cedarbaum JM
Neurol Clin; 1990 Feb; 8(1):31-49. PubMed ID: 2181267
[TBL] [Abstract][Full Text] [Related]
18. Basic mechanisms of motor fluctuations.
Sage JI; Mark MH
Neurology; 1994 Jul; 44(7 Suppl 6):S10-4. PubMed ID: 8047256
[TBL] [Abstract][Full Text] [Related]
19. Motor response complications and the function of striatal efferent systems.
Chase TN; Mouradian MM; Engber TM
Neurology; 1993 Dec; 43(12 Suppl 6):S23-7. PubMed ID: 8264907
[TBL] [Abstract][Full Text] [Related]
20. Motor fluctuations in levodopa treatment: clinical pharmacology.
Stocchi F; Bonamartini A; Vacca L; Ruggieri S
Eur Neurol; 1996; 36 Suppl 1():38-42. PubMed ID: 8791020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]